22 November 2019 - Santen Canada announced that the Canadian Agency for Drugs and Technologies in Health Canadian Drug Expert Committee released a reimbursement recommendation for Verkazia (cyclosporin 0.1%) eye drops.
This reimbursement recommendation marks an important step towards providing patients access to this new formulation of cyclosporine eye drops in Canada.
Provincial jurisdictions are the final decision makers on public reimbursement.